GSE129018
F-53B and PFOS treatments skew human cardiac differentiation towards epicardial cells by in part disrupting the WNT signaling pathway
F-53B and PFOS treatments skew human cardiac differentiation towards epicardial cells by in part disrupting the WNT signaling pathway Overall design: To dissect the potential developmental cardiac toxicity of F-53B and PFOS, we performed RNA-seq analyses for day 8 and 12 cardiac differentiation samples treated with 60 µM F-53B/PFOS. RNA sequencing were performed with BGISEQ-500 platform